Skip to main content
SpringerLink
Log in

Intervention Trials

  • Chapter
Handbook of Epidemiology

Abstract

Most human diseases have avoidable causes. This is true not only of infectious diseases, but also a large proportion of cardio-vascular diseases and cancer (Doll and Peto 1981). A major goal of epidemiology is therefore to find the causes of disease in a population and then intervene to remove them.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 199.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group (1994) The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 330:1029–1035

    Article  Google Scholar 

  • Altman DG, Schulz KF, Moher D, Egger M, Davidoff F, Elbourne D, Gotzsche PC, Lang T (2001) The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med 134:663–694

    Google Scholar 

  • Anderson GL, Prentice RL (1999) Individually randomized intervention trials for disease prevention and control. Stat Methods Med Res 8:287–309

    Article  Google Scholar 

  • Antiplatelet Trialists’ Collaboration (1994) Collaborative overview of randomised trials of antiplatelet therapy-I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 308:81–106

    Google Scholar 

  • Armitage P, Berry G (1987) Statistical methods in medical research. Blackwell, Oxford

    Google Scholar 

  • ATBC (Alpha-Tocopherol Beta Carotene) Cancer Prevention Study Group (1994) The alpha-tocopherol, beta-carotene lung cancer prevention study: design, methods, participant characteristics, and compliance. Ann Epidemiol 4:1–10

    Article  Google Scholar 

  • Atienza AA, King AC (2002) Community-based health intervention trials: an overview of methodological issues. Epidemiol Rev 24:72–79

    Article  Google Scholar 

  • Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I, Pitkin R, Rennie D, Schulz KF, Simel D, Stroup DF (1996) Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA 276:637–639

    Article  Google Scholar 

  • Bonithon-Kopp C, Kronborg O, Giacosa A, Rath U, Faivre J (2000) Calcium and fibre supplementation in prevention of colorectal adenoma recurrence: a ran domised intervention trial. European Cancer Prevention Organisation Study Group. Lancet 356:1300–1306

    Article  Google Scholar 

  • Buring J E (2002) Special issues related to randomized trials of primary prevention. Epidemiol Rev 24:67–71

    Article  Google Scholar 

  • CAST (Chinese Acute Stroke Trial) Collaborative Group (1997) CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. Lancet 349:1641–1649

    Article  Google Scholar 

  • Collins R, Gray R, Godwin J, Peto R (1987) Avoidance of large biases and large random errors in the assessment of moderate treatment effects: the need for systematic overviews. Stat Med 6:245–254

    Article  Google Scholar 

  • COMMIT Research Group (1991) Community Intervention Trial for Smoking Cessation (COMMIT): summary of design and intervention. J Natl Cancer Inst 83:1620–1628

    Article  Google Scholar 

  • Cuzick J, Sasieni P, Davies P, Adams J, Normand C, Frater A, van Ballegooijen M, van den Akker-van Marle E (2000) A systematic review of the role of human papilloma virus (HPV) testing within a cervical screening programme: summary and conclusions. Br J Cancer 83:561–565

    Article  Google Scholar 

  • De Gruttola VG, Clax P, DeMets DL, Downing GJ, Ellenberg SS, Friedman L, Gail MH, Prentice R, Wittes J, Zeger SL (2001) Considerations in the evaluation of surrogate endpoints in clinical trials. summary of a National Institutes of Health workshop. Control Clin Trials 22:485–502

    Article  Google Scholar 

  • Divine GW, Brown JT, Frazier LM (1992) The unit of analysis error in studies about physicians’ patient care behavior. J Gen Intern Med 7:623–629

    Article  Google Scholar 

  • Doll R (1998) Controlled trials: the 1948 watershed. BMJ 317:1217–1220

    Google Scholar 

  • Doll R (2002) Proof of causality: deduction from epidemiological observation. Perspect Biol Med 45:499–515

    Article  Google Scholar 

  • Doll R, Peto R (1981) The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst 66:1191–1308

    Google Scholar 

  • Donner A (1998) Some aspects of the design and analysis of cluster randomized trials. Appl Statist 47:95–113

    Google Scholar 

  • Early Breast Cancer Trialists’ Collaborative Group (1998)Tamoxifen for early breast cancer: an overview of the randomised trials. Lancet 351:1451–1467

    Article  Google Scholar 

  • Freedman LS, Graubard BI, Schatzkin A (1992) Statistical validation of intermediate endpoints for chronic diseases. Stat Med 11:167–178

    Article  Google Scholar 

  • Gambia Hepatitis Study Group (1987) The Gambia Hepatitis Intervention Study. Cancer Res 47:5782–5787

    Google Scholar 

  • Green SB (2002) Design of randomized trials. Epidemiol Rev 24:4–11

    Article  Google Scholar 

  • Heart Protection Study Collaborative Group (2002a) MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360:23–33

    Article  Google Scholar 

  • Heart Protection Study Collaborative Group (2002b) MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360:7–22

    Article  Google Scholar 

  • Hennekens CH, Buring JE (1998) Validity versus generalizability in clinical trial design and conduct. J Card Fail 4:239–241

    Article  Google Scholar 

  • Hennekens CH, Buring JE, Manson JE, Stampfer M, Rosner B, Cook NR, Belanger C, LaMotte F, Gaziano JM, Ridker PM, Willett W, Peto R (1996) Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 334:1145–1149

    Article  Google Scholar 

  • Hill AB (1962) Statistical methods in clinical and preventive medicine. Livinstone, Edinburgh

    Google Scholar 

  • Horowitz HS (1996) The effectiveness of community water fluoridation in the United States. J Public Health Dent 56:253–258

    Article  Google Scholar 

  • IARC (1998) Carotenoids. IARC handbooks of cancer prevention 2. International Agency for Research on Cancer, Lyon

    Google Scholar 

  • IARC (2003) Tobacco smoke and involuntary smoking. IARC monographs on the evaluation of carcinogenic risks to humans 83, IARC Press, Lyon

    Google Scholar 

  • IBIS Investigators (2002) First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial. Lancet 360:817–824

    Article  Google Scholar 

  • ISIS-1 (First International Study of Infarct Survival) Collaborative Group (1986) Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1. Lancet 2:57–66

    Google Scholar 

  • ISIS-2 (Second International Study of Infarct Survival) Collaborative Group (1988) Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 2:349–360

    Google Scholar 

  • ISIS-3 (Third International Study of Infarct Survival) Collaborative Group (1992) ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41,299 cases of suspected acute myocardial infarction. Lancet 339:753–770

    Article  Google Scholar 

  • ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group (1995) ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. Lancet 345:669–685

    Article  Google Scholar 

  • Jacobs ET, Giuliano AR, Roe DJ, Guillen-Rodriguez JM, Hess LM, Alberts DS, Martinez ME (2002) Intake of supplemental and total fiber and risk of colorectal adenoma recurrence in the wheat branfiber trial. Cancer Epidemiol Biomarkers Prev 11:906–914

    Google Scholar 

  • Kerry SM, Bland JM (1998) The intracluster correlation coefficient in cluster randomisation. BMJ 316:1455

    Google Scholar 

  • Klar N, Donner A (1997) The merits of matching in community intervention trials: a cautionary tale. Stat Med 16:1753–1764

    Article  Google Scholar 

  • Knatterud GL (2002) Management and conduct of randomized controlled trials. Epidemiol Rev 24:12–25

    Article  Google Scholar 

  • Koepsell TD, Wagner EH, Cheadle AC, Patrick DL, Martin DC, Diehr PH, Perrin EB, Kristal AR, Allan-Andrilla CH, Dey LJ (1992) Selected methodological issues in evaluating community-based health promotion and disease prevention programs. Annu Rev Public Health 13:31–57

    Article  Google Scholar 

  • Koutsky LA, Ault KA, Wheeler CM, Brown DR, Barr E, Alvarez FB, Chiacchierini LM, Jansen KU (2002) A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med 347:1645–1651

    Article  Google Scholar 

  • Lavori P, Kelsey J (eds) (2002) Clinical trials. Epidemiol Rev 24:1–90

    Google Scholar 

  • Medical Research Council Whooping-Cough Immunization Committee (1951) The prevention of whooping cough by vaccination. Br Med J 1951, i: 1463–1471

    Google Scholar 

  • Moher D, Schulz KF, Altman DG (2001) The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 357:1191–1194

    Article  Google Scholar 

  • Omenn GS, Goodman G, Thornquist M, Barnhart S, Balmes J, Cherniack M, Cullen M, Glass A, Keogh J, Liu D, Meyskens F, Jr., Perloff M, Valanis B, Williams J, Jr. (1996a) Chemoprevention of lung cancer: the beta-Carotene and Retinol Efficacy Trial (CARET) in high-risk smokers and asbestos-exposed workers. IARC Sci Publ 67–85

    Google Scholar 

  • Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, Keogh JP, Meyskens FL, Valanis B, Williams J H, Barnhart S, Hammar S (1996b) Effects of a combination of beta carotene andvitamin A on lung cancer and cardiovascular disease. N Engl J Med 334:1150–1155

    Article  Google Scholar 

  • Peto R, Baigent C (1998) Trials: the next 50 years. Large scale randomised evidence of moderate benefits. BMJ 317:1170–1171

    Google Scholar 

  • Peto R, Collins R, Gray R (1995) Large-scale randomized evidence: large, simple trials and overviews of trials. J Clin Epidemiol 48:23–40

    Article  Google Scholar 

  • Peto R, Doll R, Buckley JD, Sporn MB (1981) Can dietary beta-carotene materially reduce human cancer rates? Nature 290:201–208

    Article  Google Scholar 

  • Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG (1976) Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. Br J Cancer 34:585–612

    Google Scholar 

  • Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG (1977) Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br J Cancer 35:1–39

    Google Scholar 

  • Plummer M, Franceschi S (2002) Strategies for HPV prevention. Virus Res 89: 285–293

    Article  Google Scholar 

  • Prentice RL (1989) Surrogate endpoints in clinical trials: definition and operational criteria. Stat Med 8:431–440

    Article  Google Scholar 

  • Puska P, Koskela K, Pakarinen H, Puumalainen P, Soininen V, Tuomilehto J (1976) The North Karelia Project: a programme for community control of cardiovascular diseases. Scand J Soc Med 4:57–60

    Google Scholar 

  • Schatzkin A, Freedman LS, Dorgan J, McShane LM, Schiffman MH, Dawsey SM (1996) Surrogate end points in cancer research: a critique. Cancer Epidemiol Biomarkers Prev 5:947–953

    Google Scholar 

  • Schatzkin A, Freedman LS, Schiffman MH, Dawsey SM (1990) Validation of intermediate end points in cancer research. J Natl Cancer Inst 82:1746–1752

    Article  Google Scholar 

  • Schatzkin A, Gail M (2002) The promise and peril of surrogate end points in cancer research. Nat Rev Cancer 2:19–27

    Article  Google Scholar 

  • Simon R (2001) Clinical trials in cancer. In: DeVita VT, Hellman S, Rosenberg SA (eds) Cancer: principles and practice of oncology. Lippincott Williams & Wilkins, Philadelphia, PA, p 521

    Google Scholar 

  • Steering Committee of the Physicians’ Health Study Research Group (1989) Final report on the aspirin component of the ongoing Physicians’ Health Study. N Engl J Med 321:129–135

    Article  Google Scholar 

  • Stewart BW, McGregor D, Kleihues P (eds) (1996) Principles of chemoprevention, IARC Scientific Publications 139. International Agency for Research on Cancer, Lyon

    Google Scholar 

  • Temple R, Ellenberg SS (2000) Placebo-controlled trials and active-control trials in the evaluation of new treatments. Ann Int Med 133:455–463

    Google Scholar 

  • World Cancer Research Fund — American Institute for Cancer Research (CRFAICR) (1997) Food, nutrition and the prevention of cancer: a global perspective. American Institute for Cancer Research, Washington DC

    Google Scholar 

  • Yusuf S, Collins R, Peto R (1984) Why do we need some large, simple randomized trials? Stat Med 3:409–422

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Infection and Cancer Epidemiology Group, IARC, 150, Cours Albert-Thomas, 69372, Lyon Cedex 08, France

    Silvia Franceschi & Martyn Plummer

Authors
  1. Silvia Franceschi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Martyn Plummer
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Epidemiological Methods and Ethiologic Research, Bremen Institute for Prevention Research and Social Medicine (BIPS), Linzer Str. 10, 28359, Bremen, Germany

    Wolfgang Ahrens  & Iris Pigeot  & 

  2. Division of Biometrie and Data Management, Bremen Institute for Prevention Research and Social Medicine (BIPS), Linzer Str. 10, 28359, Bremen, Germany

    Wolfgang Ahrens  & Iris Pigeot  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Franceschi, S., Plummer, M. (2005). Intervention Trials. In: Ahrens, W., Pigeot, I. (eds) Handbook of Epidemiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-26577-1_9

Download citation

Publish with us

Policies and ethics

Search

Navigation